State Street’s Greenwich LifeSciences GLSI Stock Holding History

State Street’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.36M	Buy	143,086 +9,211	+7%	+$224K	﹤0.01%	3172
2026 Q1	$3.22M	Buy	133,875 +36,098	+37%	+$942K	﹤0.01%	3137
2025 Q4	$2.05M	Buy	97,777 +15,831	+19%	+$167K	﹤0.01%	3333
2025 Q3	$815K	Sell	81,946 -301	-0.4%	-$3.4K	﹤0.01%	3555
2025 Q2	$746K	Buy	82,247 +7,039	+9%	+$67K	﹤0.01%	3546
2025 Q1	$717K	Buy	75,208 +2,000	+3%	+$24.3K	﹤0.01%	3512
2024 Q4	$822K	Buy	73,208 +1,800	+3%	+$24.1K	﹤0.01%	3523
2024 Q3	$1.03M	Buy	71,408 +3,005	+4%	+$44.5K	﹤0.01%	3481
2024 Q2	$1.18M	Buy	68,403 +55,401	+426%	+$809K	﹤0.01%	3446
2024 Q1	$259K	Hold	13,002	–	–	﹤0.01%	3815
2023 Q4	$137K	Hold	13,002	–	–	﹤0.01%	3982
2023 Q3	$115K	Hold	13,002	–	–	﹤0.01%	4078
2023 Q2	$125K	Hold	13,002	–	–	﹤0.01%	4158
2023 Q1	$179K	Hold	13,002	–	–	﹤0.01%	4116
2022 Q4	$198K	Hold	13,002	–	–	﹤0.01%	4102
2022 Q3	$118K	Hold	13,002	–	–	﹤0.01%	4397
2022 Q2	$110K	Sell	13,002 -53,483	-80%	-$613K	﹤0.01%	4487
2022 Q1	$1.3M	Buy	66,485 +1,176	+2%	+$23.8K	﹤0.01%	3722
2021 Q4	$1.59M	Buy	65,309 +5,595	+9%	+$187K	﹤0.01%	3706
2021 Q3	$2.33M	Buy	59,714 +9,502	+19%	+$397K	﹤0.01%	3568
2021 Q2	$2.26M	Buy	+50,212	New	+$1.9M	﹤0.01%	3525

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

State Street's GLSI Position: Q2 2026 in Review

State Street increased its Greenwich LifeSciences (GLSI) stake by 6.9% in Q2 2026, buying an estimated $224K and bringing the position to 143,086 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3172.

State Street first reported a position in GLSI in Q2 2021 and has held it in 21 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

State Street held 143,086 shares of Greenwich LifeSciences worth $3.36M as of Q2 2026.
State Street bought 9,211 Greenwich LifeSciences shares in Q2 2026, an estimated $224K.
Greenwich LifeSciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3172 holding.
State Street first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 21 quarters since.
58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.